Type 2 diabetes: Which interventions best reduce absolute risks of adverse events?
- PMID: 19508839
Type 2 diabetes: Which interventions best reduce absolute risks of adverse events?
Abstract
Background: Benefits of interventions are usually reported as relative risk reductions. Absolute risk reductions (ARRs)-most relevant to individual patients-are reported less often.
Objectives: Estimate ARRs for interventions in a patient with diabetes mellitus.
Methods: We used the Archimedes Risk Assessment Tool to estimate 10-year risks of myocardial infarction (MI), cerebrovascular accident (CVA), end-stage renal disease (ESRD), blindness, foot ulceration, and amputation, and to estimate the ARRs associated with controlling blood pressure (BP), blood sugar, and low-density lipoprotein (LDL) cholesterol levels; moderate exercise; and taking aspirin and a beta-blocker. Our hypothetical base case was a 65-year-old white man. Three other hypothetical patients were a 50-year-old white man, a 65-year-old white woman, and a 65-year-old black man. Each patient had a 5-year history of diabetes mellitus, a sedentary lifestyle, body mass index (BMI) of 28 kg/m2, BP of 140/90 mm Hg, LDL of 120 mg/dL, high-density lipoprotein (HDL) of 45 mg/dL, and glycosylated hemoglobin (HbA1c) of 10%.
Results: For the base case, the risks of MI (22.3%) and CVA (14.4%) far exceeded the risks of ESRD, blindness, and amputation. ARRs for interventions to reduce MI risk were: aspirin, 6.8%; HbA1c to 7%, 5.1%; moderate exercise, 2.7%; BP to 130/80 mm Hg, 1.4%; and LDL to 100 mg/dL, 1.4%. The female patient had a lower ARR for aspirin and a greater ARR for exercise. The black male patient had greater ARRs for both aspirin and exercise. Estimates were similar for CVA.
Conclusion: Patients resembling our base case and its variations would probably benefit more from aspirin and moderate exercise than from all other interventions combined.
Similar articles
-
Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.Diabet Med. 2018 Jan;35(1):72-77. doi: 10.1111/dme.13533. Epub 2017 Nov 16. Diabet Med. 2018. PMID: 29057545
-
[Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].Zhonghua Shao Shang Za Zhi. 2020 Oct 20;36(10):947-952. doi: 10.3760/cma.j.cn501120-20190726-00315. Zhonghua Shao Shang Za Zhi. 2020. PMID: 33105947 Chinese.
-
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.Diabetes Obes Metab. 2014 Jul;16(7):628-35. doi: 10.1111/dom.12261. Epub 2014 Feb 19. Diabetes Obes Metab. 2014. PMID: 24443793
-
Screening and treatment by the primary care provider of common diabetes complications.Med Clin North Am. 2015 Jan;99(1):201-19. doi: 10.1016/j.mcna.2014.09.002. Epub 2014 Oct 25. Med Clin North Am. 2015. PMID: 25456651 Review.
-
Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.Cochrane Database Syst Rev. 2015 Aug 4;2015(8):CD011163. doi: 10.1002/14651858.CD011163.pub2. Cochrane Database Syst Rev. 2015. PMID: 26272648 Free PMC article. Review.
Cited by
-
30th George Swift Lecture: generalism in undergraduate medical education - what's next?Br J Gen Pract. 2012 Jun;62(599):323-5. doi: 10.3399/bjgp12X649296. Br J Gen Pract. 2012. PMID: 22687227 Free PMC article. No abstract available.
-
Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.Clin J Oncol Nurs. 2011 Aug;15 Suppl(Suppl):66-76. doi: 10.1188/11.CJON.S1.66-76. Clin J Oncol Nurs. 2011. PMID: 21816711 Free PMC article.
-
Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants.Eye (Lond). 2011 Aug;25(8):1016-9. doi: 10.1038/eye.2011.106. Epub 2011 May 13. Eye (Lond). 2011. PMID: 21587275 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical